Your leadership of the sector is health care business. Omron in a group of such companies inside, the health care sector is what kind of status? Please Mei Guan general manager make a brief Sphygmomanometer introduction.
Mei Guan: Omron's global turnover of 700 million yen, the health care industry accounts for about 10 percent of the market, is not particularly great.
Although the health care industry in the Omron Group share of at least inside, but now the growth rate is the highest cause of a field. Moreover, while sales is not high, but the profit is very good, very good growth.
Among them, China's medical health of the global health care around 8 percent.
Omron health care industry are mainly distributed in Japan, Singapore, the United States, Europe, as well as China, the five big market. I came to China to do and there are only the general manager of the year, before work in Japan.
Sohu Health: Omron health care business this high growth rates. Sphygmomanometer The situation in China and the other four major markets compared to the growth rate of China in the first few row?
Mei Guan: China is in fifth. The first is Japan, and the second is the United States, the third in Europe, is the fourth Singapore.
I am just a year ago to China, to China discovered before selling to the device from the packaging and product descriptions, as well as promotional materials are intact copy over from Japan, so higher costs, prices also compare high. For Chinese consumers, this is an expensive product. Therefore, we think: we must not Japan that a move from the same old thing, and should be considered more of China's market demand.
Starting from this year, from product design to product price changes have done is against China in the lower level that can be accepted by consumers start sales. At present four aspects, one being the price is a convenience, there is a product that is the life, and precision of these four aspects proceed.
Therefore, the target for this year we have expanded the market crowd: part of the rich, the other part of low-income families, there is a new part of the family, the different groups we have developed a variety of products.
Sohu health: your company's current business is more concentrated in the home care medical equipment or instruments?
Mei Guan: At present mainly in household products, of course, we in the hospital is a big investment. For example: a home of the Omron Blood Pressure Monitor and Meter, we also strengthen Sphygmomanometer the hospital professional input devices, such as atherosclerosis, as well as test centres such as arterial blood pressure apparatus.
Sohu health: two in the proportion of sales revenue is going on?
Mei Guan: At present, the distribution of sales from 92% of the turnover comes from the sale of the family, the hospital is 8%, but in 2010 we expect sales to the hospital to reach 15%, the remaining 85% of the family consumption.
Sohu health: Just now you mentioned that the blood pressure Dalian factory output reached 10 million units a year, China's electronic device market, Omron accounted for much market share?
Mei Guan: according to the numbers, Omron probably accounted for 55 percent. Calculated according to the amount of sales should be about 60 percent this year, we are all in China's market share of 5% of the increase.
Sohu Health: Omron growth in the China market, the sales growth rate how?
Mei Guan: growth rate is not particularly fast. For example, 03 to 04 is 106 percent, 04 to 05 is 102 percent annual growth rate, I was in the second half of last year, we can say that the Sphygmomanometer first half of the growth rate of a negative growth in the second half of the year we put a lot of advertising to a 110% growth rate. 07 financial figures may have to be after March 08 can be informed, I guess there will be a 150% growth rate.
Mei Guan: Omron's global turnover of 700 million yen, the health care industry accounts for about 10 percent of the market, is not particularly great.
Although the health care industry in the Omron Group share of at least inside, but now the growth rate is the highest cause of a field. Moreover, while sales is not high, but the profit is very good, very good growth.
Among them, China's medical health of the global health care around 8 percent.
Omron health care industry are mainly distributed in Japan, Singapore, the United States, Europe, as well as China, the five big market. I came to China to do and there are only the general manager of the year, before work in Japan.
Sohu Health: Omron health care business this high growth rates. Sphygmomanometer The situation in China and the other four major markets compared to the growth rate of China in the first few row?
Mei Guan: China is in fifth. The first is Japan, and the second is the United States, the third in Europe, is the fourth Singapore.
I am just a year ago to China, to China discovered before selling to the device from the packaging and product descriptions, as well as promotional materials are intact copy over from Japan, so higher costs, prices also compare high. For Chinese consumers, this is an expensive product. Therefore, we think: we must not Japan that a move from the same old thing, and should be considered more of China's market demand.
Starting from this year, from product design to product price changes have done is against China in the lower level that can be accepted by consumers start sales. At present four aspects, one being the price is a convenience, there is a product that is the life, and precision of these four aspects proceed.
Therefore, the target for this year we have expanded the market crowd: part of the rich, the other part of low-income families, there is a new part of the family, the different groups we have developed a variety of products.
Sohu health: your company's current business is more concentrated in the home care medical equipment or instruments?
Mei Guan: At present mainly in household products, of course, we in the hospital is a big investment. For example: a home of the Omron Blood Pressure Monitor and Meter, we also strengthen Sphygmomanometer the hospital professional input devices, such as atherosclerosis, as well as test centres such as arterial blood pressure apparatus.
Sohu health: two in the proportion of sales revenue is going on?
Mei Guan: At present, the distribution of sales from 92% of the turnover comes from the sale of the family, the hospital is 8%, but in 2010 we expect sales to the hospital to reach 15%, the remaining 85% of the family consumption.
Sohu health: Just now you mentioned that the blood pressure Dalian factory output reached 10 million units a year, China's electronic device market, Omron accounted for much market share?
Mei Guan: according to the numbers, Omron probably accounted for 55 percent. Calculated according to the amount of sales should be about 60 percent this year, we are all in China's market share of 5% of the increase.
Sohu Health: Omron growth in the China market, the sales growth rate how?
Mei Guan: growth rate is not particularly fast. For example, 03 to 04 is 106 percent, 04 to 05 is 102 percent annual growth rate, I was in the second half of last year, we can say that the Sphygmomanometer first half of the growth rate of a negative growth in the second half of the year we put a lot of advertising to a 110% growth rate. 07 financial figures may have to be after March 08 can be informed, I guess there will be a 150% growth rate.